Ten years change in post-fracture care for hip fracture patients

• Published in: Journal of bone and mineral metabolism Vol. 38; no. 2; pp. 222 - 229
• Main Authors: Shimodan, Shun, Sato, Dai, Takahashi, Kaname, Nakamura, Yumejiro, Hyakkan, Ryota, Watanabe, Takamasa, Hishimura, Ryosuke, Ota, Masahiro, Shimizu, Hirokazu, Hojo, Yoshihiro, Hasegawa, Yuichi, Chubachi, Toshiya, Yasui, Keigo, Tsujimoto, Takeru, Tsukuda, Yukinori, Asano, Tsuyoshi, Takahashi, Daisuke, Takahata, Masahiko, Iwasaki, Norimasa, Shimizu, Tomohiro
• Format: Journal Article
• Language: English
• Published: Singapore Springer Singapore 01-03-2020; Springer Nature B.V
• Subjects: Demography; Drug therapy; Fractures; Hip; Medical records; Medicine; Medicine & Public Health; Metabolic Diseases; Original Article; Orthopedics; Osteoporosis; Patients; Rehabilitation; Surgery; Hip fracture; Osteoporosis liaison service; Anti-osteoporosis therapy; Secondary fracture
• ISSN: 0914-8779; 1435-5604
• DOI: 10.1007/s00774-019-01047-3

Introduction
This multicenter, retrospective study aimed to clarify the changes in postoperative care provided by orthopaedic surgeons after hip fractures and clarify the incidence of secondary fractures requiring surgery.
Materials and methods
Subjects were patients with hip fracture treated surgically in seven hospitals during the 10-year period from January 2008 to December 2017. Data on patient demographics, comorbidities, preoperative and postoperative osteoporosis treatments, and secondary fractures were collected from the medical records.
Results
In total, 4764 new hip fractures in 982 men and 3782 women (mean age: 81.3 ± 10.0 years) were identified. Approximately 10% of patients had a history of osteoporosis drug treatment and 35% of patients received postoperative drug treatment. The proportion of patients receiving postoperative drug therapy increased by approximately 10% between 2009 and 2010, 10% between 2010 and 2011, and 10% between 2011 and 2013. Although the rate of secondary fractures during the entire period and within 3 years decreased from 2011, the rate of secondary fracture within 1 year remained at around 2% every year.
Conclusions
The approval of new osteoporosis drugs and the establishment of osteoporosis liaison services have had a positive effect on the use of postoperative drug therapy in the orthopedic field. Our finding that the rate of secondary fracture within 1 year of the initial fracture remained around 2% every year, despite improvements in postoperative drug therapy, suggests that both rehabilitation for preventing falls and early postoperative drug therapy are essential to prevent secondary fractures.